Royal Bank of Canada’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $143K | Sell |
21,061
-9,415
| -31% | -$69.6K | ﹤0.01% | 4920 |
|
|
2025
Q4 | $355K | Buy |
30,476
+8,215
| +37% | +$90.8K | ﹤0.01% | 4412 |
|
|
2025
Q3 | $259K | Sell |
22,261
-21,801
| -49% | -$264K | ﹤0.01% | 4920 |
|
|
2025
Q2 | $543K | Buy |
44,062
+22,253
| +102% | +$246K | ﹤0.01% | 4400 |
|
|
2025
Q1 | $134K | Buy |
21,809
+7,513
| +53% | +$77.8K | ﹤0.01% | 5006 |
|
|
2024
Q4 | $116K | Sell |
14,296
-4,566
| -24% | -$45.6K | ﹤0.01% | 5240 |
|
|
2024
Q3 | $153K | Buy |
18,862
+4,973
| +36% | +$26.9K | ﹤0.01% | 5023 |
|
|
2024
Q2 | $60K | Buy |
13,889
+7,079
| +104% | +$36K | ﹤0.01% | 5558 |
|
|
2024
Q1 | $28K | Sell |
6,810
-13,369
| -66% | -$46.4K | ﹤0.01% | 5771 |
|
|
2023
Q4 | $76K | Buy |
20,179
+11,490
| +132% | +$39.5K | ﹤0.01% | 5770 |
|
|
2023
Q3 | $32K | Sell |
8,689
-2,588
| -23% | -$10.3K | ﹤0.01% | 5996 |
|
|
2023
Q2 | $45K | Buy |
+11,277
| New | +$55.8K | ﹤0.01% | 5816 |
|
|
2022
Q4 | – | Sell |
-16
| Closed | – | – | 7289 |
|
|
2022
Q3 | $0 | Buy |
+16
| New | +$67 | ﹤0.01% | 7494 |
|
|
2022
Q2 | – | Sell |
-2,328
| Closed | -$13K | – | 7413 |
|
|
2022
Q1 | $13K | Sell |
2,328
-5,667
| -71% | -$25.9K | ﹤0.01% | 6828 |
|
|
2021
Q4 | $36K | Buy |
7,995
+2,867
| +56% | +$14.2K | ﹤0.01% | 6551 |
|
|
2021
Q3 | $24K | Buy |
5,128
+2,529
| +97% | +$14.7K | ﹤0.01% | 6605 |
|
|
2021
Q2 | $18K | Sell |
2,599
-37
| -1% | -$294 | ﹤0.01% | 6612 |
|
|
2021
Q1 | $26K | Sell |
2,636
-14,142
| -84% | -$149K | ﹤0.01% | 6275 |
|
|
2020
Q4 | $125K | Buy |
16,778
+16,540
| +6,950% | +$112K | ﹤0.01% | 5193 |
|
|
2020
Q3 | $1K | Buy |
238
+194
| +441% | +$974 | ﹤0.01% | 6403 |
|
|
2020
Q2 | $0 | Sell |
44
-797
| -95% | -$3.69K | ﹤0.01% | 6661 |
|
|
2020
Q1 | $3K | Sell |
841
-1,084
| -56% | -$6.12K | ﹤0.01% | 6174 |
|
|
2019
Q4 | $14K | Buy |
1,925
+1,924
| +192,400% | +$11.8K | ﹤0.01% | 6010 |
|
|
2019
Q3 | $0 | Sell |
1
-309
| -100% | -$2.6K | ﹤0.01% | 6745 |
|
|
2019
Q2 | $3K | Buy |
+310
| New | +$2.43K | ﹤0.01% | 6468 |
|
|
2018
Q2 | – | Sell |
-6
| Closed | – | – | 6555 |
|
|
2018
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 6400 |
|
|
2017
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 6581 |
|
|
2017
Q3 | $0 | Buy |
6
+5
| +500% | +$10 | ﹤0.01% | 6741 |
|
|
2017
Q2 | $0 | Buy |
+1
| New | +$3 | ﹤0.01% | 6586 |
|
|
2015
Q4 | – | Sell |
-313
| Closed | -$3K | – | 6661 |
|
|
2015
Q3 | $3K | Hold |
313
| – | – | ﹤0.01% | 6297 |
|
|
2015
Q2 | $6K | Buy |
+313
| New | +$10.7K | ﹤0.01% | 6199 |
|
Other funds holding CRMD
DTC
VCM
RA
OAM
VPM
Royal Bank of Canada's CRMD Position: Q1 2026 in Review
Royal Bank of Canada reduced its CorMedix (CRMD) stake by 31% in Q1 2026, selling an estimated $69.6K and leaving 21,061 shares worth $143K. The position accounts for ﹤0.01% of the portfolio, ranked #4920.
Royal Bank of Canada first reported a position in CRMD in Q2 2015 and has held it in 31 quarters since. The position peaked at $543K in Q2 2025. 187 funds tracked by Wall St. Rank hold CRMD as of Q1 2026.
- Royal Bank of Canada held 21,061 shares of CorMedix worth $143K as of Q1 2026.
- Royal Bank of Canada sold 9,415 CorMedix shares in Q1 2026, an estimated $69.6K.
- CorMedix made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4920 holding.
- Royal Bank of Canada first reported a position in CorMedix in Q2 2015 and has held it in 31 quarters since.
- Royal Bank of Canada's CorMedix position peaked at $543K in Q2 2025.
- 187 funds tracked by Wall St. Rank held CorMedix as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.